Gene expression changes induced by ochratoxin A in renal and hepatic tissues of male F344 rat after oral repeated administration

Toxicology and Applied Pharmacology

Volumn 230, Issue 2, 2008, Pages 197-207

  Arbillaga, Leire ^a   Vettorazzi, Ariane ^a   Gil, Ana G ^a   van Delft, Joost HM ^b   García Jalón, José Antonio ^c   López de Cerain, Adela ^a  

^a Faculty of Pharmacy   (Spain)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSIDAD DE ZARAGOZA   (Spain)

Author keywords

Gene expression; kidney and liver OTA accumulation; Male Fisher 344 rat; Ochratoxin A; Repeated oral toxicity

Indexed keywords

ANNEXIN; OCHRATOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; GENE EXPRESSION; HISTOPATHOLOGY; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; RAT; UNINDEXED SEQUENCE; UPREGULATION;

ADMINISTRATION, ORAL; ANIMALS; ANNEXINS; BODY WEIGHT; CALCIUM; GENE EXPRESSION; HOMEOSTASIS; KIDNEY; LIVER; MALE; NECROSIS; OCHRATOXINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

ANIMALIA; RATTUS;

EID: 45049088780     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.02.018     Document Type: Article

References (44)

1. Aoudia N., Tangni E.K., and Larondelle Y. Distribution of ochratoxin A in plasma and tissues of rats fed a naturally contaminated diet amended with micronized wheat fibres: effectiveness of mycotoxin sequestering activity. Food Chem. Toxicol. 46 (2008) 871-878
2. Arbillaga L., Azqueta A., Ezpeleta O., and López de Cerain A. Oxidative DNA damage induced by ochratoxin A in the HK-2 human kidney cell line: evidence of the relationship with cytotoxicity. Mutagenesis 22 (2007) 35-42
3. Arbillaga L., Azqueta A., van Delft J.H.M., and López de Cerain A. In vitro gene expression data supporting a DNA non-reactive genotoxic mechanism for ochratoxin A. Toxicol. Appl. Pharmacol. 220 (2007) 216-224
4. Baudrimont I., Betbeder A.M., Gharbi A., Pfohl-Leszkowicz A., Dirheimer G., and Creppy E.E. Effect of superoxide dismutase and catalase on the nephrotoxicity induced by subchronical administration of ochratoxin A in rats. Toxicology 89 (1994) 101-111
5. Benesic A., Mildenberger S., and Gekle M. Nephritogenic ochratoxin A interferes with hormonal signalling in immortalized human kidney epithelial cells. Pflüg. Arch. 439 (2000) 278-287
6. Castegnaro M., Mohr U., Pfohl-Leszkowicz A., Esteve J., Steinmann J., Tillmann T., Michelon J., and Bartsch H. Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int. J. Cancer 77 (1998) 70-75
7. Castegnaro M., Canadas D., Vrabcheva T., Petkova-Bocharova T., Chernozemsky I.N., and Pfohl-Leszkowicz A. Balkan endemic nephropathy: role of ochratoxin A through biomarkers. Mol. Nutr. Food Res. 50 (2006) 519-529
8. Cavin C., Delatour T., Marin-Kuan M., Holzhäuser D., Higgins L., Bezençon C., Guignard G., Junod S., Piguet D., Richoz-Payot J., Gremaux E., Hayes J.D., Nestler S., Mantle P., and Schilter B. Reduction in antioxidant defences may contribute to ochratoxin A toxicity and carcinogenicity. Toxicol. Sci. 96 (2007) 30-39
9. Creppy E.E., Schlegel M., Röschenthaler R., and Dirheimer G. Preventive action of phenylalanine on acute intoxication of ochratoxin A. C. R. Seances Acad. Sci. D. 289 (1991) 915-918
10. Dirheimer G., and Creppy E.E. Mechanism of action of ochratoxin A. In: Castegnaro M., Plestina R., Dirheimer G., Chernozemsky I.N., and Bartsch H. (Eds). Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours (1991), IARC Sci. Publ., Lyon 171-186 115
11. EFSA (European Food Safety Authority). Opinion of the Scientific Panel on contaminants in the food chain on a request from the Commission related to ochratoxin A in food. Adopted on 4 April 2006. EFSA J. 3651 (2006) 1-56
12. Hayes M.J., Rescher U., Gerke V., and Moss S.E. Annexin-actin interactions. Traffic 5 (2004) 571-576
13. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., and Speed T.P. Summaries of Affymetrix Gene Chip probe level data. Nucleic Acids Res. 31 4 (2003) e15 no
14. Jiménez A.M., López de Cerain A., González-Peñas E., and Bello J. A high performance liquid-chromatographic method for the determination of ochratoxin A in human plasma. Chromatographia 50 (1999) 457-460
15. Kamp H.G., Eisenbrand G., Janzowski C., Kiossev J., Latendresse J.R., Schlatter J., and Turesky R.J. Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats. Mol. Nutr. Food Res. 49 (2005) 1160-1167
16. Kamp H.G., Eisenbrand G., Schlatter J., Würth K., and Janzowski C. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology 206 (2005) 413-425
17. Lühe A., Hildebrand H., Bach U., Dingermann T., and Ahr H.J. A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays. Toxicol. Sci. 73 (2003) 315-328
18. Mally A., Pepe G., Ravoori S., Fiore M., Gupta R.C., Dekant W., and Mosesso P. Ochratoxin A causes DNA damage and cytogenetic effects but DNA adducts in rats. Chem. Res. Toxicol. 18 (2005) 1253-1261
19. Mally A., Völkel W., Amberg A., Kurz M., Wanek P., Eder E., Hard G., and Dekant W. Functional, biochemical and pathological effects of repeated oral administration of ochratoxin A to rats. Chem. Res. Toxicol. 18 (2005) 1242-1252
20. Mantle P. Interpretation of the pharmacokinetics of ochratoxin A in blood plasma of rats, during and after acute or chronic ingestion. Food Chem. Toxicol 46 (2008) 1808-1816
21. Mantle P., Kulinskaya E., and Nestler S. Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A. Food Addit. Contam. 22 (2005) 58-64
22. Marin-Kuan M., Nestler S., Verguet C., Bezençon C., Piguet D., Mansourian R., Holzwarth J., Grigorov M., Delatour T., Mantle P., Cavin C., and Schilter B. A Toxicogenomincs approach to identify new plausible epigenetic mechanisms of ochratoxin A carcinogenicity in rat. Toxicol. Sci. 89 (2006) 120-134
23. Millenaar F.F., Okyere J., May S.T., van Zanten M., Voesenek L.A.C.J., and Peeters A.J.M. How to decide? Different methods of calculating gene expression from short oligonucleotide array data will give different results. BMC Bioinformatics 7 (2006) 137
24. National Toxicology Program (NTP). Toxicology and carcinogenesis studies of ochratoxin A (CAS No 303-47-9) in F344/N rats (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 358 (1989) 1-142
25. Ohlmann T., Prevot D., Decimo D., Roux F., Garin J., Morley S.J., and Darlix J.L. In vitro cleavage of eIF4GI but not eIF4GII by HIV-1 protease and its effects on translation in the rabbit reticulocyte lysate system. J. Mol. Biol. 318 (2002) 9-20
26. Packer J.E. Oxidative stress, antioxidants, aging and disease. In: Gulter R.G., Packer L.B., Eratum J., and Mori A. (Eds). Oxidative Stress and Aging. (1995), Birkhäuser Verlag
27. Petkova-Bocharova T., Chernozemsky I.N., and Castegnaro M. Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria. Food Addit. Contam. 5 (1988) 299-301
28. Petroulakis E., and Wang E. Nerve growth factor specifically stimulates translation of eukaryotic elongation factor 1A-1 (eEF1A-1) mRNA by recruitment to polyribosomes in PC12 cells. J. Biol. Chem. 277 (2002) 18718-18727
29. Pfohl-Leszkowicz A., and Castegnaro M. Further arguments in favour of direct covalent binding of ochratoxin A (OTA) after metabolic biotransformation. Food Addit. Contam. 1 (2005) 1-13 Suppl
30. Rached E., Hard G.C., Blumbach K., Weber K., Draheim R., Lutz W.K., Özden S., Steger U., Dekant W., and Mally A. Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/N rats. Toxicol. Sci. 97 (2007) 288-298
31. Rahimtula A.D., Béréziat J.C., Bussacchini-Griot V., and Bartsch H. Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochem. Pharmacol. 37 (1988) 4469-4477
32. Russo A., La Fauci L., Acquaviva R., Campisi A., Raciti G., Scifo C., Renis M., Galvano G., Vanella A., and Galvano F. Ochratoxin A-induced DNA damage in human fibroblast: protective effect of cyanidin 3-O-b-D-glucoside. J. Nutr. Biochem. 16 (2005) 31-37
33. Schaaf G.J., Nijmeijer S.M., Maas R.F.M., Roestenberg P., de Groene E.M., and Fink-Gremmels J. The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochim. Biophys. Acta 1588 (2002) 149-158
34. Schilter B., Marin-Kuan M., Delatour T., Nestler S., Mantle P., and Cavin C. Ochratoxin A: potential epigenetic mechanisms of toxicity and carcinogenicity. Food Addit. Contam. 1 (2005) 88-93 Suppl
35. Sharma M.C., and Sharma M. The role of annexin II in angiogenesis and tumour progresión: a potential therapeutic target. Curr. Pharm. Des. 13 (2007) 3568-3675
36. Simarro-Doorten A.Y., Nijmeijer S., de Nijs-Tjon L., and Fink-Gremmels J. Metabolism-mediated ochratoxin A genotoxicity in the single-cell gel electrophoresis (Comet) assay. Food Chem. Toxicol. 44 (2006) 261-270
37. Simon R., and Peng A. BRB-ArrayTools, Users Guide, National Cancer Institute, Biometric Research Branch Technical Report 008 (2002), National Cancer Institute, Bethesda
38. Stemmer K., Ellinger-Ziegelbauer H., Ahr H.J., and Dietrich D.R. Carcinogen-specific gene expression profiles in short-term treated Eker and wild-type rats indicative of pathways involved in renal tumorigenesis. Cancer Res. 67 (2007) 4052-4068
39. Tomas A., Futter C., and Moss S.E. Annexin 11 is required for midbody formation and completion of the terminal phase of cytokinesis. J. Cell Biol. 165 (2004) 813-822
40. Tozlovanu M., Faucet-Marquis V., Pfohl-Leszkowicz A., and Manderville R.A. Genotoxicity of the hydroquinone metabolite of ochratoxin A: structure-activity relationships for covalent DNA adduction. Chem. Res. Toxicol. 19 (2006) 1241-1247
41. Vardhanabhuti S., Blakemore S.J., Clark S.M., Ghosh S., Stephens R.J., and Rajagolapan D. A comparison of statistical tests for detecting differential expression using Affymetrix oligonucleotide microarrays. OMICS 10 (2006) 555-566
42. Valenta H. Chromatographic methods for the determination of ochratoxin A in animal and human tissues and fluids. J. Chromatogr. 815 (1998) 75-92
43. Wu Z., and Irizarry R.A. Preprocessing of oligonucleotide array data. Nat. Biotechnol. 22 (2004) 656-658
44. Zepnik H., Völkel W., and Dekant W. Toxicokinetics of the mycotoxin ochratoxin A in F344 rats after oral administration. Toxicol. Appl. Pharmacol. 192 (2003) 36-44